BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 37319387)

  • 1. Clinical Multigene Panel Testing Identifies Racial and Ethnic Differences in Germline Pathogenic Variants Among Patients With Early-Onset Colorectal Cancer.
    Seagle HM; Keller SR; Tavtigian SV; Horton C; Holowatyj AN
    J Clin Oncol; 2023 Sep; 41(26):4279-4289. PubMed ID: 37319387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer.
    Pearlman R; Frankel WL; Swanson B; Zhao W; Yilmaz A; Miller K; Bacher J; Bigley C; Nelsen L; Goodfellow PJ; Goldberg RM; Paskett E; Shields PG; Freudenheim JL; Stanich PP; Lattimer I; Arnold M; Liyanarachchi S; Kalady M; Heald B; Greenwood C; Paquette I; Prues M; Draper DJ; Lindeman C; Kuebler JP; Reynolds K; Brell JM; Shaper AA; Mahesh S; Buie N; Weeman K; Shine K; Haut M; Edwards J; Bastola S; Wickham K; Khanduja KS; Zacks R; Pritchard CC; Shirts BH; Jacobson A; Allen B; de la Chapelle A; Hampel H;
    JAMA Oncol; 2017 Apr; 3(4):464-471. PubMed ID: 27978560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial and Ethnic Disparities in Germline Genetic Testing of Patients With Young-Onset Colorectal Cancer.
    Dharwadkar P; Greenan G; Stoffel EM; Burstein E; Pirzadeh-Miller S; Lahiri S; Mauer C; Singal AG; Murphy CC
    Clin Gastroenterol Hepatol; 2022 Feb; 20(2):353-361.e3. PubMed ID: 33359728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing germline APC and MUTYH variants in Ashkenazi Jews compared to other individuals.
    Ukaegbu C; Levi Z; Fehlmann TD; Uno H; Chittenden A; Inra JA; Grover S; Kastrinos F; Syngal S; Yurgelun MB
    Fam Cancer; 2021 Apr; 20(2):111-116. PubMed ID: 32743790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline Genetic Features of Young Individuals With Colorectal Cancer.
    Stoffel EM; Koeppe E; Everett J; Ulintz P; Kiel M; Osborne J; Williams L; Hanson K; Gruber SB; Rozek LS
    Gastroenterology; 2018 Mar; 154(4):897-905.e1. PubMed ID: 29146522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
    Yurgelun MB; Kulke MH; Fuchs CS; Allen BA; Uno H; Hornick JL; Ukaegbu CI; Brais LK; McNamara PG; Mayer RJ; Schrag D; Meyerhardt JA; Ng K; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Syngal S
    J Clin Oncol; 2017 Apr; 35(10):1086-1095. PubMed ID: 28135145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial and ethnic variation in multigene panel testing in a cohort of BRCA1/2-negative individuals who had genetic testing in a large urban comprehensive cancer center.
    Tatineni S; Tarockoff M; Abdallah N; Purrington KS; Assad H; Reagle R; Petrucelli N; Simon MS
    Cancer Med; 2022 Mar; 11(6):1465-1473. PubMed ID: 35040284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analyses in consecutive israeli jewish colorectal cancer patients.
    Fidder HH; Figer A; Geva R; Flex D; Schayek H; Avidan B; Meir SB; Friedman E
    Am J Gastroenterol; 2005 Jun; 100(6):1376-80. PubMed ID: 15929773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Inherited and Familial Component of Early-Onset Colorectal Cancer.
    Daca Alvarez M; Quintana I; Terradas M; Mur P; Balaguer F; Valle L
    Cells; 2021 Mar; 10(3):. PubMed ID: 33806975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multigene Panel Testing Yields High Rates of Clinically Actionable Variants Among Patients With Colorectal Cancer.
    Coughlin SE; Heald B; Clark DF; Nielsen SM; Hatchell KE; Esplin ED; Katona BW
    JCO Precis Oncol; 2022 Nov; 6():e2200517. PubMed ID: 36370464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Referral, Uptake, and Outcome of Genetic Counseling and Testing in Patients With Early-Onset Colorectal Cancer.
    Syed H; Sommovilla J; Burke CA; McGee S; Macaron C; Heald B; Lyu R; Schmit SL; Nair K; Kamath S; Krishnamurthi S; Khorana AA; Liska D
    J Natl Compr Canc Netw; 2023 Nov; 21(11):1156-1163.e5. PubMed ID: 37935108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of genetic testing in familial intermediate and late-onset colorectal cancer.
    Djursby M; Hansen TVO; Wadt KAW; Madsen MB; Berchtold LA; Lautrup CK; Markholt S; Jensen UB; Krogh LN; Lundsgaard M; Gerdes AM; Nilbert M; Therkildsen C
    Hum Genet; 2022 Dec; 141(12):1925-1933. PubMed ID: 35904628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
    Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
    Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Completion of Genetic Testing and Incidence of Pathogenic Germline Mutation among Patients with Early-Onset Colorectal Cancer: A Single Institution Analysis.
    Storandt MH; Rogen KR; Iyyangar A; Schnell RR; Mitchell JL; Hubbard JM; Sinicrope FA; Jatoi A; Mahipal A; Shi Q; Jin Z
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline pathogenic variant spectrum in 25 cancer susceptibility genes in Turkish breast and colorectal cancer patients and elderly controls.
    Akcay IM; Celik E; Agaoglu NB; Alkurt G; Kizilboga Akgun T; Yildiz J; Enc F; Kir G; Canbek S; Kilic A; Zemheri E; Ezberci F; Ozcelik M; Dinler Doganay G; Doganay L
    Int J Cancer; 2021 Jan; 148(2):285-295. PubMed ID: 32658311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of multigene-panel identifies pathogenic variants in several CRC-predisposing genes in patients previously tested for Lynch Syndrome.
    Hansen MF; Johansen J; Sylvander AE; Bjørnevoll I; Talseth-Palmer BA; Lavik LAS; Xavier A; Engebretsen LF; Scott RJ; Drabløs F; Sjursen W
    Clin Genet; 2017 Oct; 92(4):405-414. PubMed ID: 28195393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome Patients.
    Jansen AM; Geilenkirchen MA; van Wezel T; Jagmohan-Changur SC; Ruano D; van der Klift HM; van den Akker BE; Laros JF; van Galen M; Wagner A; Letteboer TG; Gómez-García EB; Tops CM; Vasen HF; Devilee P; Hes FJ; Morreau H; Wijnen JT
    PLoS One; 2016; 11(6):e0157381. PubMed ID: 27300758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected actionable genetic variants revealed by multigene panel testing of patients with uterine cancer.
    Heald B; Mokhtary S; Nielsen SM; Rojahn S; Yang S; Michalski ST; Esplin ED
    Gynecol Oncol; 2022 Aug; 166(2):344-350. PubMed ID: 35691755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study.
    Boumehdi AL; Cherbal F; Khider F; Oukkal M; Mahfouf H; Zebboudj F; Maaoui M
    Ann Hum Genet; 2022 Nov; 86(6):328-352. PubMed ID: 36073783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rural-urban and racial/ethnic trends and disparities in early-onset and average-onset colorectal cancer.
    Zahnd WE; Gomez SL; Steck SE; Brown MJ; Ganai S; Zhang J; Arp Adams S; Berger FG; Eberth JM
    Cancer; 2021 Jan; 127(2):239-248. PubMed ID: 33112412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.